Newsroom

Newsroom

Spatial interrogation of tertiary lymphoid structures (TLS) in colorectal carcinoma (CRC) tumor microenvironment (TME) using the MultiOmyxTM assay

Literature
Read More

Ubiquitin ligases implicated as predictive biomarkers for poor outcome to immunotherapy in melanoma patients

Literature
Read More

Use of Receptor Occupancy Assays on cells from Peripheral Blood as a Surrogate Model of the Tumor Microenvironment

Literature
Read More

Validation of a next-generation-sequencing heme clinical assay for detection of immunoglobulin heavy chain clonality and somatic hypermutation in chronic lymphocytic leukemia

Literature
Read More

NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR™ Assay MRD Assay at AACR 2022

Press Release
Read More

NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D

Press Release
Read More

NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022

Press Release
Read More

Using Real-World Lab Data Insights to Improve Biomarker Testing in Lung Cancer

Blog
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients